OSPOMYV 60 mg/mL
denosumab · INJECTION, SOLUTION · Cordavis Limited
No Recall History
Plain English
OSPOMYV is a injection, solution containing denosumab at 60 mg/mL, taken subcutaneous. Manufactured by Cordavis Limited.
Key Facts
- Brand Name
- OSPOMYV
- Generic Name
- denosumab
- NDC Code (Product)
83457-012- Manufacturer
- Cordavis Limited
- Strength
- 60 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761392
- Drug Class
- RANK Ligand Inhibitor [EPC]
- Marketing Start
- 10/10/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
osteonecrosis of jaw1,463 reports
diarrhoea1,094 reports
fatigue1,046 reports
nausea1,016 reports
malignant neoplasm progression995 reports
neutropenia862 reports
metastases to bone797 reports
off label use772 reports
anaemia718 reports
vomiting589 reports
Frequently Asked Questions
What is OSPOMYV used for?
OSPOMYV contains denosumab. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is OSPOMYV a controlled substance?
OSPOMYV is not classified as a controlled substance by the DEA.
What is the generic name for OSPOMYV?
The generic name for OSPOMYV is denosumab. There are 11 other brand versions of denosumab.
What is the NDC code for OSPOMYV 60 mg/mL?
The NDC (National Drug Code) for OSPOMYV 60 mg/mL is 83457-012, listed by Cordavis Limited.